Cargando…

Cannabinoid Receptor Type-2 in B Cells Is Associated with Tumor Immunity in Melanoma

SIMPLE SUMMARY: In this study we investigated the role of cannabinoid receptor 2 (CB2R) on immune cells in melanoma and found significantly improved overall survival in patients with high intra-tumoral CB2R gene expression. In human melanoma, CB2R is predominantly expressed in B cells, as shown usin...

Descripción completa

Detalles Bibliográficos
Autores principales: Gruber, Thomas, Robatel, Steve, Kremenovic, Mirela, Bäriswyl, Lukas, Gertsch, Jürg, Schenk, Mirjam
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8073134/
https://www.ncbi.nlm.nih.gov/pubmed/33923757
http://dx.doi.org/10.3390/cancers13081934
_version_ 1783684063939264512
author Gruber, Thomas
Robatel, Steve
Kremenovic, Mirela
Bäriswyl, Lukas
Gertsch, Jürg
Schenk, Mirjam
author_facet Gruber, Thomas
Robatel, Steve
Kremenovic, Mirela
Bäriswyl, Lukas
Gertsch, Jürg
Schenk, Mirjam
author_sort Gruber, Thomas
collection PubMed
description SIMPLE SUMMARY: In this study we investigated the role of cannabinoid receptor 2 (CB2R) on immune cells in melanoma and found significantly improved overall survival in patients with high intra-tumoral CB2R gene expression. In human melanoma, CB2R is predominantly expressed in B cells, as shown using a previously published single-cell RNA sequencing (scRNA-seq) dataset and by performing RNAscope. In a murine melanoma model, tumor growth was enhanced in CB2R-deficient mice. In-depth analysis of tumor-infiltrating lymphocytes using scRNA-seq showed less differentiated B cells in CB2R-deficient tumors, favoring the induction of regulatory T cells (T(reg)) and an immunosuppressive tumor microenvironment. Taken together, these data indicate a central role of CB2R on B cells in regulating tumor immunity. These results contribute to the understanding of the role of CB2R in tumor immunity and facilitate the development of new CB2R-targeted anti-cancer drugs. ABSTRACT: Agents targeting the endocannabinoid system (ECS) have gained attention as potential cancer treatments. Given recent evidence that cannabinoid receptor 2 (CB2R) regulates lymphocyte development and inflammation, we performed studies on CB2R in the immune response against melanoma. Analysis of The Cancer Genome Atlas (TCGA) data revealed a strong positive correlation between CB2R expression and survival, as well as B cell infiltration in human melanoma. In a murine melanoma model, CB2R expression reduced the growth of melanoma as well as the B cell frequencies in the tumor microenvironment (TME), compared to CB2R-deficient mice. In depth analysis of tumor-infiltrating B cells using single-cell RNA sequencing suggested a less differentiated phenotype in tumors from Cb2r(−/−) mice. Thus, in this study, we demonstrate for the first time a protective, B cell-mediated role of CB2R in melanoma. This gained insight might assist in the development of novel, CB2R-targeted cancer therapies.
format Online
Article
Text
id pubmed-8073134
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-80731342021-04-27 Cannabinoid Receptor Type-2 in B Cells Is Associated with Tumor Immunity in Melanoma Gruber, Thomas Robatel, Steve Kremenovic, Mirela Bäriswyl, Lukas Gertsch, Jürg Schenk, Mirjam Cancers (Basel) Article SIMPLE SUMMARY: In this study we investigated the role of cannabinoid receptor 2 (CB2R) on immune cells in melanoma and found significantly improved overall survival in patients with high intra-tumoral CB2R gene expression. In human melanoma, CB2R is predominantly expressed in B cells, as shown using a previously published single-cell RNA sequencing (scRNA-seq) dataset and by performing RNAscope. In a murine melanoma model, tumor growth was enhanced in CB2R-deficient mice. In-depth analysis of tumor-infiltrating lymphocytes using scRNA-seq showed less differentiated B cells in CB2R-deficient tumors, favoring the induction of regulatory T cells (T(reg)) and an immunosuppressive tumor microenvironment. Taken together, these data indicate a central role of CB2R on B cells in regulating tumor immunity. These results contribute to the understanding of the role of CB2R in tumor immunity and facilitate the development of new CB2R-targeted anti-cancer drugs. ABSTRACT: Agents targeting the endocannabinoid system (ECS) have gained attention as potential cancer treatments. Given recent evidence that cannabinoid receptor 2 (CB2R) regulates lymphocyte development and inflammation, we performed studies on CB2R in the immune response against melanoma. Analysis of The Cancer Genome Atlas (TCGA) data revealed a strong positive correlation between CB2R expression and survival, as well as B cell infiltration in human melanoma. In a murine melanoma model, CB2R expression reduced the growth of melanoma as well as the B cell frequencies in the tumor microenvironment (TME), compared to CB2R-deficient mice. In depth analysis of tumor-infiltrating B cells using single-cell RNA sequencing suggested a less differentiated phenotype in tumors from Cb2r(−/−) mice. Thus, in this study, we demonstrate for the first time a protective, B cell-mediated role of CB2R in melanoma. This gained insight might assist in the development of novel, CB2R-targeted cancer therapies. MDPI 2021-04-16 /pmc/articles/PMC8073134/ /pubmed/33923757 http://dx.doi.org/10.3390/cancers13081934 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Gruber, Thomas
Robatel, Steve
Kremenovic, Mirela
Bäriswyl, Lukas
Gertsch, Jürg
Schenk, Mirjam
Cannabinoid Receptor Type-2 in B Cells Is Associated with Tumor Immunity in Melanoma
title Cannabinoid Receptor Type-2 in B Cells Is Associated with Tumor Immunity in Melanoma
title_full Cannabinoid Receptor Type-2 in B Cells Is Associated with Tumor Immunity in Melanoma
title_fullStr Cannabinoid Receptor Type-2 in B Cells Is Associated with Tumor Immunity in Melanoma
title_full_unstemmed Cannabinoid Receptor Type-2 in B Cells Is Associated with Tumor Immunity in Melanoma
title_short Cannabinoid Receptor Type-2 in B Cells Is Associated with Tumor Immunity in Melanoma
title_sort cannabinoid receptor type-2 in b cells is associated with tumor immunity in melanoma
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8073134/
https://www.ncbi.nlm.nih.gov/pubmed/33923757
http://dx.doi.org/10.3390/cancers13081934
work_keys_str_mv AT gruberthomas cannabinoidreceptortype2inbcellsisassociatedwithtumorimmunityinmelanoma
AT robatelsteve cannabinoidreceptortype2inbcellsisassociatedwithtumorimmunityinmelanoma
AT kremenovicmirela cannabinoidreceptortype2inbcellsisassociatedwithtumorimmunityinmelanoma
AT bariswyllukas cannabinoidreceptortype2inbcellsisassociatedwithtumorimmunityinmelanoma
AT gertschjurg cannabinoidreceptortype2inbcellsisassociatedwithtumorimmunityinmelanoma
AT schenkmirjam cannabinoidreceptortype2inbcellsisassociatedwithtumorimmunityinmelanoma